Novo Nordisk: How a Danish Pharma Giant Became the Shadow Superpower of Global Gluttony
Somewhere between the Arctic Circle and a midtown Manhattan pharmacy counter, the Danish firm Novo Nordisk has quietly become the most influential geopolitical actor nobody voted for. What began in 1923 as a modest insulin cooperative in a Copenhagen loft has metastasized—appropriately—into a global empire whose market cap now exceeds the GDP of oil-rich Norway….